Cite
Significant association of serum autoantibodies to TYMS, HAPLN1 and IGFBP5 with early stage canine malignant mammary tumours.
MLA
Chang, Shih-Chieh, et al. “Significant Association of Serum Autoantibodies to TYMS, HAPLN1 and IGFBP5 with Early Stage Canine Malignant Mammary Tumours.” Veterinary and Comparative Oncology, vol. 19, no. 1, Mar. 2021, pp. 172–82. EBSCOhost, https://doi.org/10.1111/vco.12657.
APA
Chang, S.-C., Yuan, S. H.-C., Li, C.-Y., Chang, H.-M., Wang, H.-C., Pan, Y.-A., Hsueh, P.-C., Wu, C.-C., Yang, Y., & Liu, H.-P. (2021). Significant association of serum autoantibodies to TYMS, HAPLN1 and IGFBP5 with early stage canine malignant mammary tumours. Veterinary and Comparative Oncology, 19(1), 172–182. https://doi.org/10.1111/vco.12657
Chicago
Chang, Shih-Chieh, Stephen Hsien-Chi Yuan, Chia-Yin Li, Huan-Ming Chang, Heng-Cian Wang, Yun-An Pan, Pei-Chun Hsueh, Chih-Ching Wu, Youngsen Yang, and Hao-Ping Liu. 2021. “Significant Association of Serum Autoantibodies to TYMS, HAPLN1 and IGFBP5 with Early Stage Canine Malignant Mammary Tumours.” Veterinary and Comparative Oncology 19 (1): 172–82. doi:10.1111/vco.12657.